|
|
|
Insider
Information: |
Westphal Christoph H |
Relationship: |
10% Owner |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
6,222,903 |
|
Indirect Shares
|
9,212,891 |
|
|
Direct
Value |
$11,131,506 |
|
|
Indirect Value
|
$387,338,594 |
|
|
Total
Shares |
15,435,794 |
|
|
Total
Value |
$398,470,099 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2004-06-25 |
0 |
2004-06-25 |
76,648 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director, 10% Owner |
2004-05-27 |
0 |
2004-06-03 |
2,409,970 |
Premium* |
|
Verastem, Inc. |
VSTM |
Executive Chairman, Di... |
2015-06-30 |
665,224 |
2015-06-30 |
1,500,063 |
Premium* |
|
Tempest Therapeutics, Inc |
TPST |
Director, 10% Owner |
2014-03-07 |
701,927 |
2014-03-07 |
3,825,421 |
Premium* |
|
Salarius Pharmaceuticals, Inc |
SLRX |
10% Owner |
2018-10-16 |
3,941,118 |
2018-10-16 |
0 |
Premium* |
|
Tscan Therapeutics, Inc. |
TCRX |
10% Owner |
2021-07-20 |
914,634 |
2021-07-20 |
1,400,789 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
137 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SLRX |
Salarius Pharmaceuticals,... |
10% Owner |
|
2018-10-16 |
4 |
S |
$0.92 |
$2,941,053 |
I/I |
(3,212,861) |
0 |
0 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2013-09-11 |
4 |
B |
$10.53 |
$51,071 |
I/I |
4,850 |
4,850 |
2.25 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2004-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
4,905,930 |
74,227 |
|
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2004-06-25 |
4 |
B |
$6.50 |
$1,040,000 |
I/I |
160,000 |
76,648 |
2.1 |
- |
|
VSTM |
Verastem, Inc. |
President and CEOOfficer |
|
2012-01-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
125,714 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2004-05-27 |
4 |
B |
$6.00 |
$1,875,000 |
I/I |
312,500 |
300,170 |
2.25 |
- |
|
VSTM |
Verastem, Inc. |
President and CEOOfficer |
|
2012-01-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
502,857 |
|
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2015-06-30 |
4 |
D |
$6.86 |
$18,165 |
D/D |
(2,648) |
665,224 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2015-03-31 |
4 |
D |
$10.49 |
$29,550 |
D/D |
(2,817) |
674,328 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2014-12-31 |
4 |
D |
$8.86 |
$24,542 |
D/D |
(2,770) |
677,789 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2015-01-08 |
4 |
D |
$9.19 |
$53,394 |
D/D |
(5,810) |
683,601 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2014-09-30 |
4 |
D |
$8.60 |
$23,753 |
D/D |
(2,762) |
685,516 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2014-12-19 |
4 |
B |
$8.50 |
$12,750 |
D/D |
1,500 |
687,016 |
2.81 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2015-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
11,622 |
689,411 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Director |
|
2014-01-02 |
4 |
D |
$11.40 |
$74,009 |
D/D |
(6,492) |
690,380 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2014-06-30 |
4 |
D |
$9.52 |
$52,646 |
D/D |
(5,530) |
694,734 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Director |
|
2013-09-30 |
4 |
D |
$12.71 |
$77,455 |
D/D |
(6,094) |
695,072 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Director |
|
2013-10-31 |
4 |
A |
$9.99 |
$7,996 |
D/D |
800 |
695,872 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Director |
|
2013-11-18 |
4 |
AB |
$9.60 |
$9,602 |
D/D |
1,000 |
696,872 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2014-03-31 |
4 |
D |
$10.36 |
$57,498 |
D/D |
(5,550) |
698,264 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Executive Chairman |
|
2014-05-14 |
4 |
B |
$7.56 |
$15,120 |
D/D |
2,000 |
700,264 |
2.81 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-04-02 |
4 |
D |
$9.44 |
$55,148 |
D/D |
(5,842) |
700,289 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Director |
|
2013-07-01 |
4 |
D |
$13.88 |
$82,211 |
D/D |
(5,923) |
701,166 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Executive Officer |
|
2013-04-09 |
4 |
A |
$8.98 |
$9,068 |
D/D |
1,000 |
701,289 |
0 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2012-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
701,927 |
|
- |
|
137 Records found
|
|
Page 1 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|